Multiple tumour markers for diagnosis, management and follow-up of potentially resectable lung cancer.
The present prospective study has been carried out to evaluate the role of tumour markers in the preoperative assessment and follow-up of patients with potentially resectable lung cancer. The carcinoembryonic antigen (CEA), neuron specific enolase (NSE), and tissue polypeptide antigen (TPA) have been preoperatively measured in 133 lung cancer patients and in 75 healthy smokers. The same tumour markers have been serially determined during the 12 to 30 month-follow-up of 53 subjects who had a complete resection. In screening for localized lung cancer, TPA determination was the single most accurate diagnostic test. The combined measurement of several tumour markers did not result in a greater diagnostic accuracy of the assay. In predicting lung cancer unresectability, CEA, though being the most suitable test, allowed preoperative detection of only one third of patients with unremovable tumours. In monitoring the postresectional course of subjects who had a complete resection, the combined measurement of TPA and NSE proved to be a very reliable predictor of disease recurrence.